A randomized phase III trial of high dose interleukin-2 versus subcutaneous interleukin-2/interferon

Curr Urol Rep. 2002 Feb;3(1):11-2. doi: 10.1007/s11934-002-0004-9.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / secondary
  • Clinical Trials, Phase III as Topic
  • Humans
  • Injections, Subcutaneous
  • Interferons / administration & dosage*
  • Interleukin-2 / administration & dosage*
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / pathology
  • Randomized Controlled Trials as Topic

Substances

  • Antineoplastic Agents
  • Interleukin-2
  • Interferons